Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06730347 |
| Consolidated Lead Sponsor | MacroGenics |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 80 participants (ESTIMATED) |
| Registered Start Date | 2025-05-01 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| UCLA Health and Jonsson Comprehensive Cancer Center | Los Angeles, CA | Open Hospital Dossier -> |
| MD Anderson Cancer Center | Houston, TX | Open Hospital Dossier -> |
| National Cancer Center | Goyang-si, South Korea | Open Hospital Dossier -> |
| Yonsei University Health System, Severance Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.